# TEXAS BIOMEDICAL RESEARCH INSTITUTE: An intranasal live-attenuated vaccine to combat Lassa virus infection

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | TEXAS BIOMEDICAL RESEARCH INSTITUTE |
| Location | SAN ANTONIO, TX |
| Project | An intranasal live-attenuated vaccine to combat Lassa virus infection |
| Project number | 1R21AI198928-01 |
| Mechanism | R21 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $238,463 |
| Awarded | 2026-09-14 |
| Project period | 2026-09-14 to 2028-08-31 |
| UEI | J4EYPCJDQ1H6 |

## Why this score
- Award of $238,463.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11353320). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.